Nuvation Bio Inc.
NUVB
$2.25
$0.073.21%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -649.24% | -542.39% | -464.87% | 34.18% | 27.25% |
| Total Depreciation and Amortization | 207.66% | 140.28% | 89.86% | 7.18% | 11.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6,281.91% | 3,778.52% | 3,210.41% | -45.43% | -37.90% |
| Change in Net Operating Assets | -2,416.11% | -432.66% | -154.64% | -356.97% | 115.67% |
| Cash from Operations | -91.79% | -43.39% | -3.87% | 28.88% | 29.25% |
| Capital Expenditure | -134.78% | -55.37% | 69.31% | 77.60% | 81.35% |
| Sale of Property, Plant, and Equipment | -- | 133.33% | 7.69% | 7.69% | 7.69% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,130.36% | 299.64% | 89.57% | 294.43% | -85.93% |
| Cash from Investing | 1,275.44% | 325.94% | 135.85% | 302.42% | -85.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 677.87% | 320.33% | 105.57% | -73.23% | -52.68% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -47.29% | 47.65% | 170.62% | 113.30% | -52.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.15% | 104.94% | 69.80% | 105.83% | -86.60% |